Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Strong Trading Volume – Still a Buy?

by · The Markets Daily

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) saw unusually-high trading volume on Tuesday . 82,115 shares changed hands during trading, a decline of 39% from the previous session’s volume of 135,097 shares.The stock last traded at $8.51 and had previously closed at $8.65.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on SGIOY shares. Zacks Research raised Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR has an average rating of “Buy”.

Check Out Our Latest Research Report on Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 1.3%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.46 and a current ratio of 1.58. The stock has a market cap of $14.53 billion, a price-to-earnings ratio of 10.68, a price-to-earnings-growth ratio of 3.31 and a beta of 0.08. The business’s 50 day moving average is $9.27 and its 200 day moving average is $9.90.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) last announced its earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 13.56%. The company had revenue of $881.71 million for the quarter, compared to the consensus estimate of $895.52 million. Equities analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.

Featured Stories